These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12615751)

  • 21. ACE inhibition in cardiovascular disease.
    Francis GS
    N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood pressure and cardiovascular risk in the HOPE study.
    Taylor R
    Lancet; 2002 Jun; 359(9323):2117-8; author reply 2118. PubMed ID: 12086795
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of ramipril on cardiovascular events in high-risk patients.
    O'Rourke MF; Nichols WW
    N Engl J Med; 2000 Jul; 343(1):64-5; author reply 66. PubMed ID: 10896544
    [No Abstract]   [Full Text] [Related]  

  • 24. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
    Mancini GB; Stewart DJ
    Can J Cardiol; 2001 May; 17 Suppl A():15A-7A. PubMed ID: 11381289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The HOPE Study. What does it contribute to general practice?].
    Mann J; Sleight P
    MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE inhibitors to prevent cardiovascular events in high-risk patients.
    VandeKieft GK
    J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].
    Traut V
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292
    [No Abstract]   [Full Text] [Related]  

  • 29. More than just hype.
    Shishkov W
    CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821617
    [No Abstract]   [Full Text] [Related]  

  • 30. [Info-Congress. The HOPE Study: Demonstration of the cardiovascular protection of ramipril, an ACE-inhibitor].
    Scheen AJ
    Rev Med Liege; 1999 Oct; 54(10):835-6. PubMed ID: 10605322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.
    Tu K; Mamdani MM; Jacka RM; Forde NJ; Rothwell DM; Tu JV
    CMAJ; 2003 Mar; 168(5):553-7. PubMed ID: 12615747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the effect of a countywide protected learning time scheme on prescribing rates of ramipril: interrupted time series study.
    Siriwardena AN; Fairchild P; Gibson S; Sach T; Dewey M
    Fam Pract; 2007 Feb; 24(1):26-33. PubMed ID: 17052988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should you take an ACE inhibitor?
    Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):1-2. PubMed ID: 10740441
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of a converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients].
    Hébert M
    Presse Med; 2000 Apr; 29(14):790-2. PubMed ID: 10816721
    [No Abstract]   [Full Text] [Related]  

  • 36. [New breakthrough for ACE inhibitors. HOPE Study: hope for all vascular patients?].
    MMW Fortschr Med; 1999 Oct; 141(42):66-7. PubMed ID: 10912112
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE in the hole for heart patients...
    Health News; 1999 Dec; 5(15):5. PubMed ID: 10633584
    [No Abstract]   [Full Text] [Related]  

  • 38. The kidney in cardiovascular disease.
    Kasiske BL
    Ann Intern Med; 2001 Apr; 134(8):707-9. PubMed ID: 11304109
    [No Abstract]   [Full Text] [Related]  

  • 39. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the relevance of the HOPE study in general practice?
    Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
    Int J Clin Pract; 2001 Sep; 55(7):449-57. PubMed ID: 11594254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.